ロード中...
Power and Sample Size Calculations for SNP Association Studies with Censored Time-to-Event Outcomes
For many clinical studies in cancer, germline DNA is prospectively collected for the purpose of discovering or validating Single Nucleotide Polymorphisms associated with clinical outcomes. The primary clinical endpoint for many of these studies are time-to-event outcomes such as time of death or dis...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3592339/ https://ncbi.nlm.nih.gov/pubmed/22685040 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/gepi.21645 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|